Shin-ichi Ikeda
Nagoya City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shin-ichi Ikeda.
Chemical Communications | 2002
Shin-ichi Ikeda; Hirokazu Kondo; Taro Arii; Kazunori Odashima
A catalytic enantioselective intermolecular [2 + 2 + 2] cycloaddition of one molecule of alkene (enone) and two molecules of alkyne was developed in the presence of a nickel complex modified by chiral monodentate oxazoline ligands, which have not previously been used as chiral ligands for transition metals in asymmetric catalysts, and an aluminium phenoxide.
Tetrahedron | 1998
Dong-Mei Cui; Takao Tsuzuki; Kaori Miyake; Shin-ichi Ikeda; Yoshiro Sato
Abstract The nickel-catalyzed intermolecular coupling of allyl acetate or allyl carbonate with alkynes and alkynyltins was carried out in the presence of LiCl to give 3,6-dien-1-yne regio- and stereoselectively. On the other hand, the intramolecular cyclization and coupling of ω-alkynyl electrophiles with alkynyltins gave five-membered cyclic products.
Chemical Communications | 2006
Shin-ichi Ikeda; Kaori Suzuki; Kazunori Odashima
The Ni-catalyzed coupling of allyl chlorides and enynes has been developed; the cyclization of enynes was triggered by the addition of pi-allylnickel species to the alkyne part, followed by the incorporation of the alkene part.
Chemical Communications | 2001
Naoyoshi Mori; Shin-ichi Ikeda; Kazunori Odashima
A binary metal system of nickel(0) and zinc(II) phenoxide catalyzed the chemo- and regioselective cyclotrimerization of monoynes.
Nature Communications | 2018
Naomi Tsuburaya; Kengo Homma; Tsunehiko Higuchi; Andrii Balia; Hiroyuki Yamakoshi; Norio Shibata; Seiichi Nakamura; Hidehiko Nakagawa; Shin-ichi Ikeda; Naoki Umezawa; Nobuki Kato; Satoshi Yokoshima; Masatoshi Shibuya; Manabu Shimonishi; Hirotatsu Kojima; Takayoshi Okabe; Tetsuo Nagano; Isao Naguro; Keiko Imamura; Haruhisa Inoue; Takao Fujisawa; Hidenori Ichijo
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder. Despite its severity, there are no effective treatments because of the complexity of its pathogenesis. As one of the underlying mechanisms of Cu, Zn superoxide dismutase (SOD1) gene mutation-induced ALS, SOD1 mutants (SOD1mut) commonly interact with an endoplasmic reticulum-resident membrane protein Derlin-1, triggering motoneuron death. However, the importance of SOD1-Derlin-1 interaction in in vitro human model and in vivo mouse model remains to be elucidated. Here, we identify small-molecular-weight compounds that inhibit the SOD1-Derlin-1 interaction by screening approximately 160,000 compounds. The inhibitor prevents 122 types of SOD1mut from interacting with Derlin-1, and significantly ameliorates the ALS pathology both in motoneurons derived from patient induced pluripotent stem cells and in model mice. Our data suggest that the SOD1-Derlin-1 interaction contributes to the pathogenesis of ALS and is a promising drug target for ALS treatment.Amyotrophic lateral sclerosis (ALS) is a neurological disease that leads to loss of voluntary muscle movement. Here, the authors screen for molecules that disrupt interaction between SOD1, a protein linked to ALS, and Derlin-1, and find an inhibitor that reduces pathology in an ALS mouse model.
Chemical Communications | 2000
Shin-ichi Ikeda; Hirokazu Kondo; Naoyoshi Mori
A nickel and aluminium system including monodentate oxazoline ligands catalyzed the regioselective cyclotrimerization of enones and alkynes.
Accounts of Chemical Research | 2000
Shin-ichi Ikeda
Angewandte Chemie | 2003
Shin-ichi Ikeda
Journal of the American Chemical Society | 1994
Shin-ichi Ikeda; Yoshiro Sato
Journal of the American Chemical Society | 1999
Naoyoshi Mori; Shin-ichi Ikeda; Yoshiro Sato